Skip to main content
Clinical Trials/NCT03485066
NCT03485066
Unknown
N/A

Multimodal Associations of Human Brain Plasticity Investigated With Simultaneous PET/MR Imaging

Rupert Lanzenberger1 site in 1 country40 target enrollmentMay 1, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Neuronal Plasticity
Sponsor
Rupert Lanzenberger
Enrollment
40
Locations
1
Primary Endpoint
Training induced changes in imaging parameters
Last Updated
6 years ago

Overview

Brief Summary

Background: Neuronal plasticity is the brain's ability to continuously adapt to experiences and learning of new skills. Although this affects multiple characteristics of the brain such as structure, function and metabolism, direct interactions between these aspects are largely missing.

Aim: Using recent advancements in neuroimaging we aim to identify novel relationships how neuronal plasticity is related across these characteristics.

Design: 40 healthy subjects will undergo two simultaneous PET/MR measurements at baseline and after 4 weeks. During the measurements a cognitively challenging task will be performed and the training group (20 subjects) will practice during the 4-week period.

Implications: We combine simultaneous PET/MR and novel task-specific PET imaging to study brain metabolism, structure and function in a single measurement session. This provides optimal sensitivity for assessment of multimodal neuroplasticity associations. Knowledge how cognitive training affects multiple characteristics of the brain will also increase our understanding of disorders like depression, dementia and brain injuries, since these are diagnosed with cognitive evaluations. Considering the vast usage of the applied imaging procedures in diagnosis and therapy monitoring, the thorough investigation of multimodal associations offers benefit for the interpretability of neuroimaging in clinical routine.

Detailed Description

Methodological details: Each subject will undergo two PET/MR examinations. Imaging will include PET as well as acquisition of structural and functional MRI. Task-specific glucose metabolism will be quantified with the radioligand \[18F\]FDG. Gray matter volume and white matter microstructure will be assessed with T1-weighted and diffusion weighted MRI, respectively. Functional imaging will focus on functional connectivity during rest and task as well as cerebral blood flow as acquired with ASL.

Registry
clinicaltrials.gov
Start Date
May 1, 2017
End Date
November 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Rupert Lanzenberger
Responsible Party
Sponsor Investigator
Principal Investigator

Rupert Lanzenberger

Assoc.Prof. PD MD, Head of Neuroimaging Labs

Medical University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Age range 21-30 years
  • Right-handedness
  • Willingness and competence to sign the informed consent form

Exclusion Criteria

  • History of or current physical, neurological or psychiatric disorder
  • History of or current substance abuse or medication including antipsychotic, antidepressant and antianxiety agents
  • Pregnancy or current breastfeeding
  • Contraindications for MRI-scanning (e.g., metal implants, steel grafts, etc), including dental implants causing signal artifacts
  • For subjects participating in earlier studies using ionizing radiation, the total radiation exposure of 30mSv over the last 10 years must not be exceeded, as specified in the Austrian legislation on radiation protection
  • Regular players of the video game Tetris (3 years before scanning).
  • Failure to comply with the study protocol or to follow the instructions of the investigating team

Outcomes

Primary Outcomes

Training induced changes in imaging parameters

Time Frame: 4 weeks

Imaging parameters are glucose metabolism (\[18F\]FDG PET), cerebral blood flow (arterial spin labeling MRI), functional connectivity (resting-state and task fMRI), gray matter volume (T1-weighted MRI) and white matter structure (diffusion weighted MRI)

Secondary Outcomes

  • Cognitive performance(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials